Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03598270
Title Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer (ANITA)
Acronym ANITA
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Grupo Espanol de Investigacion en Cancer de Ovario
Age Groups: adult | senior
Covered Countries ITA | FRA | ESP | DEU | BEL

No variant requirements are available.